Ask Orbit
Supply & Distribution
Supply & Distribution/Distribution & Sell-Through

Distribution & Sell-Through

Product movement, channel performance and sell-through efficiency.

1 – 30 Jun 2026·All Divisions·All Regions·All Wholesalers
Demo Data
Orbit Distribution Briefing
Updated 14 min ago

Distribution remains healthy nationally, although sell-through continues to lag within two wholesalers. Cardiaxol demand exceeds replenishment in Gauteng, while Respireze inventory remains slow-moving in the Coastal region. Redistribution of approximately R1.2m would improve overall channel efficiency.

Distribution Coverage
91%
Healthy
+1.4 pp vs prior period
Sell-Through Rate
77%
Below
-4 pp WoW
Distribution Points
1,428
+34 activated
Channel Efficiency
82
score out of 100
Products at Distribution Risk
3
Watch
Cardiaxol, Respireze, Pulmavent
Revenue Delayed
R2.4m
Recover
in constrained accounts
Distribution funnel
Manufacturer → Warehouse → Wholesaler → Customer → Sell-Out
Manufacturer
100%R292m
-4 pp conversion
Warehouse
96%R281m
-5 pp conversion
Wholesaler
91%R266m
-13 pp conversion
Customer
78%R228m
-7 pp conversion
Sell-Out
71%R208m
Bottleneck detectedWholesaler → Customer conversion at 78% (target 85%)
Sell-through trend
Actual vs Forecast vs Target · weekly
Channel efficiency
Score · share of national volume
Wholesaler B94
26.4% of national volume
Wholesaler C91
12.8% of national volume
National Distribution Group88
18.3% of national volume
Independent Group82
7.1% of national volume
Regional Health Supply74
9.2% of national volume
Wholesaler A66
23.2% of national volume
Key Account Y58
2.4% of national volume
Product movement ranking
Weekly units moved · top 6 SKUs
Risks & opportunities
Prioritised for this period
Risks
Low sell-through at Wholesaler A-4 pp
Cardiaxol distribution imbalanceR2.1m
Respireze slow-moving CoastalR1.2m
Uneven channel performance3 chnl
Opportunities
Increase regional distribution WC+R1.2m
Reallocate Respireze inventory+R0.8m
Improve Wholesaler A pull-through+R1.6m
Expand Wholesaler C Cardiaxol+R0.7m
Cross-page investigation
Follow the commercial thread
Inventory & Stock Health
Where is stock constrained or accumulating?
Commercial Flow
Trace the bottleneck end-to-end
Products & Brands
Which SKUs drive the gap?
Wholesalers & Key Accounts
Account-level distribution health
Distribution detail
Product · region · wholesaler with sell-through and Orbit recommendation
ProductRegionWholesalerDistributionSell-throughStockRevenueRiskOrbit recommendation
Cardiaxol 20mgGautengWholesaler A96%62%LowR8.4mHighExpedite replenishment
Cardiaxol 40mgGautengWholesaler B100%88%HealthyR6.1mLowSustain
Respireze InhalerWestern CapeWholesaler A92%54%ExcessR3.2mMedRedistribute R1.2m
Gastraven 20mgCape MetroWholesaler C84%92%HealthyR4.6mLowExtend distribution
Pulmavent DPIKwaZulu-NatalNDG71%68%LowR2.1mMedRefresh call plan
Metaform 850Free StateRHS68%72%HealthyR1.9mMedReprice + promote
Neurospen 500Eastern CapeWholesaler A74%48%ExcessR1.4mHighReduce inbound
Gastraven ChewableCape MetroWholesaler C62%96%HealthyR1.8mLowScale distribution